SYRS

Syros Pharmaceuticals, Inc. Common Stock
SYRS

Overview Fund Activity
Delisted

SYRS was delisted on the 19th of March, 2025.

Back to rankings

76 hedge funds and large institutions have $246M invested in Syros Pharmaceuticals, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
–
Holders Change %
0%
% of All Funds
1.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
25
Reduced
25
Closed
8
Calls
$464K
Puts
$279K
Net Calls
+$185K
Net Calls Change
+$308K

Top Buyers

1
AIM
ARK Investment Management
Florida
+$5.03M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.92M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.79M
4
WCM
Wedge Capital Management
North Carolina
+$731K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$519K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$2.41M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.63M
3
Deutsche Bank
Deutsche Bank
Germany
-$1.59M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.01M
5
Two Sigma Investments
Two Sigma Investments
New York
-$715K
Name Holding Trade Value Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$60.1M +$1.92M +16,141 +3%
FP
2
Flagship Pioneering
Massachusetts
$38.2M – – –
AIM
3
ARK Investment Management
Florida
$26.5M +$5.03M +42,232 +23%
RG
4
Redmile Group
California
$19.7M +$297K +2,490 +2%
BlackRock
5
BlackRock
New York
$19.2M +$358K +3,004 +2%
DM
6
Deerfield Management
New York
$15.1M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$12.4M +$519K +4,356 +4%
BBA
8
Baker Bros. Advisors
New York
$6.85M – – –
State Street
9
State Street
Massachusetts
$4.55M +$359K +3,011 +9%
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$4.41M +$98.7K +829 +2%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$3.9M -$3.22K -27 -0.1%
Northern Trust
12
Northern Trust
Illinois
$3.62M +$338K +2,835 +10%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$2.7M +$137K +1,149 +5%
CS
14
Candriam SCA
Luxembourg
$2.43M – – –
Millennium Management
15
Millennium Management
New York
$2.06M -$2.41M -20,262 -54%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$1.79M +$1.79M +15,035 New
EAM
17
Eventide Asset Management
Massachusetts
$1.79M – – –
Charles Schwab
18
Charles Schwab
California
$1.54M +$202K +1,697 +15%
Connor, Clark & Lunn Investment Management (CC&L)
19
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.41M +$191K +1,600 +16%
PAM
20
Panagora Asset Management
Massachusetts
$1.12M – – –
BCM
21
Bridgeway Capital Management
Texas
$1.02M – – –
Point72 Asset Management
22
Point72 Asset Management
Connecticut
$975K -$1.01M -8,496 -51%
GCP
23
GSA Capital Partners
United Kingdom
$969K +$502K +4,220 +108%
Jacobs Levy Equity Management
24
Jacobs Levy Equity Management
New Jersey
$939K +$26.2K +220 +3%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$925K +$84.1K +706 +10%
1
2 3 4